Laure Deflube
Principal Research Scientist
Vertex Pharmaceuticals




As a Principal Research Scientist at Vertex Pharmaceuticals, She led projects designed to improve AAV-based gene therapy. With over 15 years of experience in molecular biology and cell biology, She have a strong background in engineering cell lines, developing and optimizing assays, and designing novel DNA plasmids and sequences. She have also worked on diverse research fields, including immuno oncology, cystic fibrosis, and RNA virus replication, demonstrating my ability to quickly acquire new knowledge and apply my technical skills to different therapeutic platforms.

She is self-motivated, passionate about science and learning, and she thrive in collaborative and cross-functional environments. She enjoys team work and vigorous scientific discussion, and she values the input and feedback of my colleagues and stakeholders. Working at Vertex has allowed her to grow her understanding of the industry, especially in regards to the complex manufacturing processes of gene and cell therapies. Her mission is to bring challenging projects to successful completion and contribute to the development of innovative and life-changing treatments.

Post-doctoral Fellow
Boston University Chobanian & Avedisian School of Medicine
Virology, Immunology & Microbiology


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Deflubé LR, Cressey TN, Hume AJ, Olejnik J, Haddock E, Feldmann F, Ebihara H, Fearns R, Mühlberger E. Ebolavirus polymerase uses an unconventional genome replication mechanism. Proc Natl Acad Sci U S A. 2019 04 23; 116(17):8535-8543.View Related Profiles. PMID: 30962389; PMCID: PMC6486738; DOI: 10.1073/pnas.1815745116;
     
  2. Manhart WA, Pacheco JR, Hume AJ, Cressey TN, Deflubé LR, Mühlberger E. A Chimeric Lloviu Virus Minigenome System Reveals that the Bat-Derived Filovirus Replicates More Similarly to Ebolaviruses than Marburgviruses. Cell Rep. 2018 09 04; 24(10):2573-2580.e4.View Related Profiles. PMID: 30184492; PMCID: PMC6159894; DOI: 10.1016/j.celrep.2018.08.008;
     
  3. Braun MR, Deflubé LR, Noton SL, Mawhorter ME, Tremaglio CZ, Fearns R. RNA elongation by respiratory syncytial virus polymerase is calibrated by conserved region V. PLoS Pathog. 2017 12; 13(12):e1006803.View Related Profiles. PMID: 29281742; PMCID: PMC5760109; DOI: 10.1371/journal.ppat.1006803;
     
  4. Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflubé LR, Ruedas JB, Connor JH, Ebihara H, Mühlberger E. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening. Antiviral Res. 2017 Oct; 146:21-27.View Related Profiles. PMID: 28807685; PMCID: PMC5654650; DOI: 10.1016/j.antiviral.2017.08.005;
     
  5. Olejnik J, Forero A, Deflubé LR, Hume AJ, Manhart WA, Nishida A, Marzi A, Katze MG, Ebihara H, Rasmussen AL, Mühlberger E. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages. J Virol. 2017 Jun 01; 91(11).View Related Profiles. PMID: 28331091; PMCID: PMC5432886; DOI: 10.1128/JVI.00179-17;
     
  6. Nelson EV, Schmidt KM, Deflubé LR, Doganay S, Banadyga L, Olejnik J, Hume AJ, Ryabchikova E, Ebihara H, Kedersha N, Ha T, Mühlberger E. Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions. J Virol. 2016 Aug 15; 90(16):7268-84.View Related Profiles. PMID: 27252530; PMCID: PMC4984654; DOI: 10.1128/JVI.00459-16;
     
  7. Tremaglio CZ, Noton SL, Deflubé LR, Fearns R. Respiratory syncytial virus polymerase can initiate transcription from position 3 of the leader promoter. J Virol. 2013 Mar; 87(6):3196-207.View Related Profiles. PMID: 23283954; PMCID: PMC3592119; DOI: 10.1128/JVI.02862-12;
     
  8. Noton SL, Deflubé LR, Tremaglio CZ, Fearns R. The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter. PLoS Pathog. 2012; 8(10):e1002980.View Related Profiles. PMID: 23093940; PMCID: PMC3475672; DOI: 10.1371/journal.ppat.1002980;
     
  9. Kumar SR, Deflube L, Biswas M, Shobana R, Elankumaran S. Genetic characterization of swine influenza viruses (H3N2) isolated from Minnesota in 2006-2007. Virus Genes. 2011 Oct; 43(2):161-76. PMID: 21603982; DOI: 10.1007/s11262-011-0618-4;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 9 publications over 7 distinct years, with a maximum of 3 publications in 2017

YearPublications
20111
20121
20131
20161
20173
20181
20191

Contact for Mentoring:

72 E. Concord St Evans Building
Boston MA 02118
Google Map


Deflube's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_